Palouse Capital Management Inc. increased its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 74.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 65,369 shares of the pharmacy operator’s stock after acquiring an additional 27,912 shares during the quarter. Walgreens Boots Alliance comprises about 1.7% of Palouse Capital Management Inc.’s investment portfolio, making the stock its 25th biggest position. Palouse Capital Management Inc.’s holdings in Walgreens Boots Alliance were worth $5,048,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Commonwealth Bank of Australia increased its holdings in shares of Walgreens Boots Alliance by 139.5% during the 2nd quarter. Commonwealth Bank of Australia now owns 46,167 shares of the pharmacy operator’s stock worth $3,614,000 after purchasing an additional 26,893 shares during the period. IBM Retirement Fund increased its holdings in shares of Walgreens Boots Alliance by 88.1% during the 2nd quarter. IBM Retirement Fund now owns 22,903 shares of the pharmacy operator’s stock worth $2,004,000 after purchasing an additional 10,729 shares during the period. Andra AP fonden increased its holdings in shares of Walgreens Boots Alliance by 35.3% during the 2nd quarter. Andra AP fonden now owns 58,300 shares of the pharmacy operator’s stock worth $4,565,000 after purchasing an additional 15,200 shares during the period. Schwab Charles Investment Management Inc. increased its holdings in shares of Walgreens Boots Alliance by 5.4% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,019,739 shares of the pharmacy operator’s stock worth $236,476,000 after purchasing an additional 154,995 shares during the period. Finally, Birinyi Associates Inc. increased its holdings in shares of Walgreens Boots Alliance by 9.0% during the 2nd quarter. Birinyi Associates Inc. now owns 9,100 shares of the pharmacy operator’s stock worth $713,000 after purchasing an additional 750 shares during the period. Hedge funds and other institutional investors own 61.41% of the company’s stock.
In related news, Director John Anthony Lederer bought 20,000 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, October 26th. The shares were bought at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the completion of the transaction, the director now owns 50,000 shares of the company’s stock, valued at $3,350,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the transaction, the director now owns 16,415 shares in the company, valued at $1,105,878.55. The disclosure for this sale can be found here. 14.80% of the stock is owned by insiders.
Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $71.94 on Friday. The company has a market cap of $72,850.00, a PE ratio of 14.06, a price-to-earnings-growth ratio of 1.28 and a beta of 1.22. Walgreens Boots Alliance Inc has a 12-month low of $63.82 and a 12-month high of $88.00. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.07 and a quick ratio of 0.59.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, beating the Zacks’ consensus estimate of $1.21 by $0.10. The firm had revenue of $30.15 billion for the quarter, compared to analyst estimates of $29.93 billion. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The company’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same period in the previous year, the business earned $1.07 earnings per share. equities research analysts predict that Walgreens Boots Alliance Inc will post 5.54 EPS for the current year.
Walgreens Boots Alliance declared that its Board of Directors has initiated a share buyback program on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to repurchase shares of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s management believes its shares are undervalued.
The company also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th were given a $0.40 dividend. The ex-dividend date was Friday, November 10th. This represents a $1.60 dividend on an annualized basis and a yield of 2.22%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 42.33%.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
What are top analysts saying about Walgreens Boots Alliance? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Walgreens Boots Alliance and related companies.